戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1 o thin filament activation by substituting 2 deoxy-ATP (dATP; a strong cross-bridge augmenter) for AT
2                         Replacing ATP with 2 deoxy-ATP (dATP) increased F-actin speed for both groups
3 utanedione monoxime) or augmentation (with 2 deoxy-ATP) had no greater effect in cardiac muscle with
4 ucture of hOAS1 in complex with dsRNA and 2'-deoxy ATP at 2.7 A resolution, which reveals the mechani
5  The time-course of VCF responses to ATP, 2'-deoxy ATP, 3'-deoxy ATP, Ap5A and alphabetameATP were ag
6                           Substitution of 2'-deoxy ATP (dATP) for ATP as substrate for actomyosin res
7  ion (NO3 (-) ) and N(6) -(2-phenylethyl)-2'-deoxy-ATP (d-PATP), which almost completely rectifies th
8 e custom synthesized N(6)-(2-phenylethyl)-2'-deoxy-ATP (P-dATP), an analog combining the chemical mod
9 ngly, an ATP analogue, N6-(2-phenylethyl)-2'-deoxy-ATP (P-dATP), can increase the open probability (P
10                         Here we show that 2'-deoxy-ATP (dATP), but not 3'-deoxy-ATP, increases the ac
11                                       ATP, 2-deoxy ATP (dATP), CTP, and UTP support isometric force a
12 s of cardiac trabeculae with either ATP or 2-deoxy-ATP (dATP) as the substrate for contraction.
13 y demonstrated that cardiac myosin can use 2-deoxy-ATP (dATP) as an energy substrate, that it enhance
14 ntrol by substitution of ATP (5.0 mM) with 2-deoxy-ATP (dATP) (5.0 mM) or by lowering [ATP] to 0.5 mM
15  were altered by either replacing ATP with 2-deoxy-ATP (dATP) or by reducing [ATP].
16 oss-bridge cycling rate was increased with 2-deoxy-ATP.
17 se of VCF responses to ATP, 2'-deoxy ATP, 3'-deoxy ATP, Ap5A and alphabetameATP were agonist dependen
18 differences with respect to inhibition by 3'-deoxy-ATP.
19 -(7-diethylaminocoumarin-3-carbonylamino)-3'-deoxy-ATP (deac-aminoATP), which undergoes a 20-fold inc
20 luenza RNA polymerase, the K(i) value for 3'-deoxy-ATP (0.4-0.6 microM) is approximately 100-fold low
21                Whereas the K(i) value for 3'-deoxy-ATP (105-117 microM) is similar to the K(m) value
22 MANT-3'-dATP [2'-O-(N-methylanthraniloyl)-3'-deoxy-ATP] (Ki, 16.7 nM).
23 we show that 2'-deoxy-ATP (dATP), but not 3'-deoxy-ATP, increases the activity of G551D-CFTR by appro
24                       In the active site, 3'-deoxy-ATP and a single metal ion are well positioned for
25 of the 2'-deoxyribose leads to ligands (mant-deoxy-ATP [dATP], mant-deoxy-ADP) with inverse agonist a
26 as active with ATP and partially active with deoxy-ATP, but lacked measurable activity with other nuc

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。